an overview of vigil personalized engineered autologous tumor cells in ovarian cancer
Published 6 years ago • 259 plays • Length 1:31Download video MP4
Download video MP3
Similar videos
-
28:33
michael j. birrer md, phd: future of ovarian cancer treatment: personalized medicine
-
58:12
enhancing personalized medicine in ovarian cancer: advances in parp inhibition and novel modalities
-
25:30
innovative and emerging trials in ovarian cancer
-
6:53
ovarian cancer: oncologist answers 5 questions about risk factors, screening & treatment | stanford
-
8:05
targeted therapy options for advanced ovarian cancer
-
8:17
ovarian cancer story what led me to go to the hospital scary
-
1:08:46
targeting ovarian cancer
-
42:00
prospects for targeted therapy in ovarian cancer - by michael birrer, md, phd
-
27:39
novel therapeutics in ovarian cancer: what to watch
-
28:07
dr andrew clamp: advances in targeted treatment for ovarian cancer
-
1:29:06
the advanced ovarian cancer treatment palette: candid conversations on parp inhibitors
-
31:11
targeting tumor associated macrophages in ovarian cancer
-
2:03
on the scene at #sgomtg: ovarian cancer research highlights
-
1:50
an overview of a study exploring mirvetuximab soravtansine in ovarian cancer
-
24:34
top advances in ovarian cancer therapy
-
4:42
olaparib: an opportunity for personalised medicine in brca-related ovarian cancer
-
25:20
ovarian cancer 2021: recent advance in treatment
-
0:34
improving immunotherapy for the treatment of patients with ovarian cancer
-
3:05
an overview of parp inhibitors in ovarian cancer
-
0:50
oncotarget: targeted ovarian cancer treatment
-
57:11
personalizing advanced ovarian cancer treatment with parp inhibitors and novel approaches